BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1593293)

  • 1. Evaluation of chemically sensitive patients.
    Fiedler N; Maccia C; Kipen H
    J Occup Med; 1992 May; 34(5):529-38. PubMed ID: 1593293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobehavioral performance in multiple chemical sensitivities.
    Bolla KI
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 2):S52-4. PubMed ID: 8921556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom profile of multiple chemical sensitivity in actual life.
    Saito M; Kumano H; Yoshiuchi K; Kokubo N; Ohashi K; Yamamoto Y; Shinohara N; Yanagisawa Y; Sakabe K; Miyata M; Ishikawa S; Kuboki T
    Psychosom Med; 2005; 67(2):318-25. PubMed ID: 15784800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple chemical sensitivity multiorgan dysesthesia, multiple symptom complex, and multiple confusion: problems in diagnosing the patient presenting with unexplained multisystemic symptoms.
    Salvaggio JE; Terr AI
    Crit Rev Toxicol; 1996 Nov; 26(6):617-31. PubMed ID: 8958467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal chemoreception in patients with multiple chemical sensitivities: a double-blind investigation.
    Hummel T; Roscher S; Jaumann MP; Kobal G
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 2):S79-86. PubMed ID: 8921561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequelae of fume exposure in confined space welding: a neurological and neuropsychological case series.
    Bowler RM; Nakagawa S; Drezgic M; Roels HA; Park RM; Diamond E; Mergler D; Bouchard M; Bowler RP; Koller W
    Neurotoxicology; 2007 Mar; 28(2):298-311. PubMed ID: 17169432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Executive and amnestic functions of a group of first-degree relatives of schizophrenic patients].
    Laurent A; d'Amato T; Naegele B; Murry P; Baro P; Foussard N; Spitz F; Dalery J
    Encephale; 2000; 26(5):67-74. PubMed ID: 11192806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study.
    Majer M; Welberg LA; Capuron L; Miller AH; Pagnoni G; Reeves WC
    Psychosom Med; 2008 Sep; 70(7):829-36. PubMed ID: 18606722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: a neuropsychological comparison.
    Tumkaya S; Karadag F; Oguzhanoglu NK; Tekkanat C; Varma G; Ozdel O; Ateşçi F
    Psychiatry Res; 2009 Jan; 165(1-2):38-46. PubMed ID: 18995914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of confounding variables in the assessment of neurobehavioural effects of chronic solvent exposure.
    Williamson AM
    Neurotoxicology; 1996; 17(3-4):761-7. PubMed ID: 9086499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pest controllers: a high-risk group for Multiple Chemical Sensitivity (MCS)?
    Bornschein S; Hausteiner C; Pohl C; Jahn T; Angerer J; Foerstl H; Zilker T
    Clin Toxicol (Phila); 2008 Mar; 46(3):193-200. PubMed ID: 18344101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple chemical sensitivity (MCS)--differential diagnosis in clinical neurotoxicology: a German perspective.
    Altenkirch H
    Neurotoxicology; 2000 Aug; 21(4):589-97. PubMed ID: 11022866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities.
    Buchwald D; Garrity D
    Arch Intern Med; 1994 Sep; 154(18):2049-53. PubMed ID: 8092909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychology and psychology of MCS.
    Fiedler N; Kipen H; Deluca J; Kelly-McNeil K; Natelson B
    Toxicol Ind Health; 1994; 10(4-5):545-54. PubMed ID: 7778113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.